Theralase Technologies Inc. (TLT) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.629x

Based on the latest financial reports, Theralase Technologies Inc. (TLT) has a cash flow conversion efficiency ratio of -0.629x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.12K ≈ $-497.05K USD) by net assets (CA$1.09 Million ≈ $790.45K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Theralase Technologies Inc. - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Theralase Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Theralase Technologies Inc. (TLT) financial obligations for a breakdown of total debt and financial obligations.

Theralase Technologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theralase Technologies Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Eltek Ltd NASDAQ:ELTK	0.044x
Cumberland Pharmaceuticals Inc NASDAQ:CPIX	0.007x
Flanigans Enterprises Inc NYSE MKT:BDL	0.062x
Monalisa KO:012690	0.021x
Scilex Holding Company NASDAQ:SCLX	-0.046x
Anson Resources Ltd AU:ASN	-0.082x
Schwälbchen Molkerei Jakob Berz AG F:SMB	N/A
OneConstruction Group Limited Ordinary Shares NASDAQ:ONEG	-0.837x

Annual Cash Flow Conversion Efficiency for Theralase Technologies Inc. (2001–2024)

The table below shows the annual cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see TLT market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$2.07 Million ≈ $1.50 Million	CA$-3.33 Million ≈ $-2.41 Million	-1.609x	+24.73%
2023-12-31	CA$1.91 Million ≈ $1.38 Million	CA$-4.07 Million ≈ $-2.95 Million	-2.137x	-28.78%
2022-12-31	CA$3.09 Million ≈ $2.24 Million	CA$-5.13 Million ≈ $-3.71 Million	-1.660x	-108.79%
2021-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.03 Million ≈ $-2.92 Million	-0.795x	-63.83%
2020-12-31	CA$9.16 Million ≈ $6.63 Million	CA$-4.45 Million ≈ $-3.22 Million	-0.485x	-2.38%
2019-12-31	CA$13.86 Million ≈ $10.02 Million	CA$-6.57 Million ≈ $-4.75 Million	-0.474x	+61.07%
2018-12-31	CA$998.64K ≈ $722.40K	CA$-1.22 Million ≈ $-879.39K	-1.217x	+41.54%
2017-12-31	CA$2.05 Million ≈ $1.48 Million	CA$-4.26 Million ≈ $-3.08 Million	-2.082x	-142.84%
2016-12-31	CA$5.69 Million ≈ $4.12 Million	CA$-4.88 Million ≈ $-3.53 Million	-0.858x	-7.39%
2015-12-31	CA$6.32 Million ≈ $4.57 Million	CA$-5.04 Million ≈ $-3.65 Million	-0.799x	+27.19%
2014-12-31	CA$3.31 Million ≈ $2.39 Million	CA$-3.63 Million ≈ $-2.62 Million	-1.097x	-111.05%
2013-12-31	CA$1.76 Million ≈ $1.28 Million	CA$-916.67K ≈ $-663.11K	-0.520x	-105.54%
2012-12-31	CA$-64.73K ≈ $-46.82K	CA$-606.72K ≈ $-438.89K	9.373x	+405.21%
2011-12-31	CA$455.16K ≈ $329.25K	CA$-1.40 Million ≈ $-1.01 Million	-3.071x	-663.82%
2010-12-31	CA$2.53 Million ≈ $1.83 Million	CA$-1.02 Million ≈ $-735.94K	-0.402x	-3323.44%
2009-12-31	CA$3.49 Million ≈ $2.52 Million	CA$-40.95K ≈ $-29.62K	-0.012x	+92.02%
2008-12-31	CA$2.39 Million ≈ $1.73 Million	CA$-351.19K ≈ $-254.05K	-0.147x	-41.17%
2007-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-351.49K ≈ $-254.26K	-0.104x	-1262.74%
2006-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-25.78K ≈ $-18.65K	-0.008x	-130.39%
2005-12-31	CA$3.39 Million ≈ $2.45 Million	CA$85.33K ≈ $61.73K	0.025x	+130.40%
2004-12-31	CA$1.05 Million ≈ $762.12K	CA$-87.23K ≈ $-63.10K	-0.083x	+82.82%
2003-12-31	CA$399.21K ≈ $288.78K	CA$-192.39K ≈ $-139.17K	-0.482x	+13.24%
2002-12-31	CA$87.35K ≈ $63.19K	CA$-48.52K ≈ $-35.10K	-0.555x	+7.87%
2001-12-31	CA$137.03K ≈ $99.13K	CA$-82.62K ≈ $-59.76K	-0.603x	--

About Theralase Technologies Inc.

V:TLT Canada Medical Devices

Market Cap

$58.45 Million

CA$80.80 Million CAD

Market Cap Rank

#21286 Global

#746 in Canada

Share Price

CA$0.31

Change (1 day)

-4.69%

52-Week Range

CA$0.15 - CA$0.39

All Time High

CA$0.58